Skip to content
left end
left end
right end


Transcatheter aortic valve implantation (TAVI)

You have been diagnosed with a condition called aortic stenosis - narrowing of the aortic valve. Your cardiologist has decided that you may benefit from having your valve replaced.

Conventionally, aortic valve replacement was performed using open heart surgery. However, increasingly, a more minimally invasive approach is recommended in patients who have an increased operative risk. This new method of treatment is called transcatheter aortic valve implantation (TAVI).

The heart team at the Bristol Heart Institute (a cardiologist and cardiothoracic surgeon) have discussed your case and recommended TAVI rather than conventional open heart surgery.



The MitraClip is indicated for the percutaneous reduction of  significant symptomatic mitral regurgitation (MR) due to primary  abnormality of the mitral apparatus ( degenerative MR. The team includes a cardiac surgeon experienced in mitral valve surgery and a cardiologist experienced in mitral valve disease.

The MitraClip system is a catheter-based device which can reduce mitral regurgitation without the need for open heart surgery. It is indicated for use in patients who are at unacceptably risk from conventional mitral valve repair or replacement.

 ?? images of Mitraclip and link to video ?


Paravalvular leak  closure

Paravalvular regurgitation affects some patients after implanted prosthetic heart valves. Tran-Oesophageal echocardiographic imaging is key for characterising the defect location, size, and shape of regurgitant valve.